- Home
- ZURA vs UHG Comparison
ZURA vs UHG Comparison
Compare ZURA & UHG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZURA
- UHG
- Stock Information
- Founded
- ZURA 2022
- UHG 2004
- Country
- ZURA United States
- UHG United States
- Employees
- ZURA N/A
- UHG N/A
- Industry
- ZURA Biotechnology: Biological Products (No Diagnostic Substances)
- UHG Homebuilding
- Sector
- ZURA Health Care
- UHG Consumer Discretionary
- Exchange
- ZURA Nasdaq
- UHG Nasdaq
- Market Cap
- ZURA 69.9M
- UHG 205.1M
- IPO Year
- ZURA N/A
- UHG N/A
- Fundamental
- Price
- ZURA $1.10
- UHG $2.85
- Analyst Decision
- ZURA Buy
- UHG
- Analyst Count
- ZURA 7
- UHG 0
- Target Price
- ZURA $14.33
- UHG N/A
- AVG Volume (30 Days)
- ZURA 689.4K
- UHG 218.7K
- Earning Date
- ZURA 08-08-2025
- UHG 08-07-2025
- Dividend Yield
- ZURA N/A
- UHG N/A
- EPS Growth
- ZURA N/A
- UHG N/A
- EPS
- ZURA N/A
- UHG 0.76
- Revenue
- ZURA N/A
- UHG $449,877,017.00
- Revenue This Year
- ZURA N/A
- UHG N/A
- Revenue Next Year
- ZURA N/A
- UHG N/A
- P/E Ratio
- ZURA N/A
- UHG $3.74
- Revenue Growth
- ZURA N/A
- UHG 5.24
- 52 Week Low
- ZURA $0.97
- UHG $1.60
- 52 Week High
- ZURA $5.07
- UHG $6.93
- Technical
- Relative Strength Index (RSI)
- ZURA 45.84
- UHG 46.12
- Support Level
- ZURA $1.00
- UHG $2.62
- Resistance Level
- ZURA $1.22
- UHG $3.93
- Average True Range (ATR)
- ZURA 0.09
- UHG 0.35
- MACD
- ZURA -0.00
- UHG -0.12
- Stochastic Oscillator
- ZURA 45.45
- UHG 17.56
About ZURA Zura Bio Limited
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
About UHG United Homes Group Inc
United Homes Group Inc operates as a homebuilder which operates with a land-light idea in the Southeast. The company currently has a presence in South Carolina, North Carolina, and Georgia and focuses on providing high-quality, affordable homes for the entry-level and first-move-up segments. The company has three reportable segments: GSH South Carolina, Rosewood, and Other.